Illumina PRS grant winner investigates genetic linkage between opioid use disorder and chronic pain

11 April 2024

Illumina congratulates Emma Johnson, PhD, Assistant Professor in Psychiatry at Washington University School of Medicine in St. Louis for winning the Illumina Polygenic Research Grant Contest. Professor Johnson and her colleagues, Arpana Agrawal, PhD, Professor of Psychiatry, and Simon Haroutounian, PhD, Chief of Clinical Research at the Washington University Pain Center, will use Illumina and Allelica technology to genotype at least 1000 surgery patients from an ongoing P5 study (PI: Dr. Haroutounian) to understand the transition from acute to chronic postoperative pain. Ultimately, this research aims to develop polygenic risk scores (PRS) for chronic pain and Opioid Use Disorder (OUD), enabling clinicians to one day more effectively manage and prevent post-surgical pain, as well as providing a resource for stratification of high-risk individuals who may develop OUD alongside chronic pain. Learn more about the PRS grant winning submission here: M-GL-02756 For Research Use Only. Not for use in diagnostic procedures. © 2024 Illumina, Inc. All Rights Reserved. #polygenicriskscores #infinium #illumina Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos View Illumina webinars View Illumina support videos Facebook: LinkedIn: Instagram: Twitter:

Share this article on